Showing results (151-160 of 219) with videos related to
Sort By:
Pageof 22
Clinical Endocrinology|August 1, 1989
Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Scottish Automated Follow-Up Register GroupA J Hedley, R E Young, S J Jones, et al.Clinical Endocrinology|January 7, 1999
Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid DrugsG Benker, D Reinwein, G Kahaly, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 1998
The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interactionL S Murray, D I Jodrell, J G Morrison, et al.British Journal of Cancer|January 1, 1997
A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastasesJ D Howell, C S McArdle, D J Kerr, et al.Anticancer Research|May 1, 1991
Oncogene transfection of mink lung cells: effect on growth characteristics in vitro and in vivoM Z Khan, D A Spandidos, D J Kerr, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2003
A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solutionK B Hosie, D J Kerr, J A Gilbert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracilD J Kerr, J A Ledermann, C S McArdle, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Melphalan concentration and distribution in the tissues of tumour-bearing limbs treated by isolated limb perfusionR N Scott, R Blackie, D J Kerr, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancerD I Jodrell, W Oster, D J Kerr, et al.British Journal of Cancer|July 1, 1988
A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitorD Veale, J Carmichael, B M Cantwell, et al.Pageof 22